BackDisc Medicine Overview

Disc Medicine Long Term Debt

Track Disc Medicine's long-term debt ($1.2M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$1.21M
96.02% YoYΔ $-29.08M vs prior year quarter

Peer trimmed avg / median

Loading

Disc Medicine Long Term Debt History

Loading

Disc Medicine vs. peers: Long Term Debt Comparison

Loading

Disc Medicine Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Disc Medicine (IRON) FAQ

As of the most recent data (June 2026), IRON shows a long-term debt of $1.2M. That compares with $30M in the prior-year period — down 96.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IRON's long-term debt is now $1.2M (was $30M) — a 96.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Disc Medicine is outperforming or lagging.

Tracking IRON's long-term debt over time shows whether Disc Medicine is scaling, shrinking, or reshaping that part of the business. The current reading is $1.2M That compares with $30M in the prior-year period — down 96.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Disc Medicine's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $1.2M) with ownership activity and broader fundamentals.

Disc Medicine's long-term debt is $1.2M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.